University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor (NMDAR)—long studied primarily for ...

and the NMDA receptor (NMDAR), has shown potential as a treatment for major depressive disorder (MDD), and other severe stress-related conditions. The study highlights the proposed efficacy of ...

and the NMDA receptor, NMDAR, has shown potential as a treatment for major depressive disorder, MDD, and other severe stress-related conditions. The study highlights the proposed efficacy of combining ...

Researchers have discovered that the NMDA receptor (NMDAR), known for its role in learning and memory, also stabilizes brain activity by setting baseline neural network activity.

Wanting to offer hope to others, a man who was paralyzed and a woman with a rare brain disease shared their recovery stories.

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor (NMDAR)-;long studied primarily for its role in learning and memory-;also plays a crucial role in stabilizing ...

New Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

Roche has entered into an agreement with Evotec to fund the Phase II clinical development of a selective N-methyl-D-aspartate (NMDA) receptor antagonist, EVT 101, for patients with treatment ...

By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst ...